Geneva Partners, LLC Illumina, Inc. Transaction History

Geneva Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$372.84 - $481.5 $279,630 - $361,125	-750 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$361.28 - $504.76 $270,960 - $378,570	750 New	750 $288,000
Q1 2019 May 10, 2019	SELL	$272.57 - $321.18 $329,809 - $388,627	-1,210 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$272.46 - $366.54 $1.78 Million - $2.4 Million	-6,540 Reduced 84.39%	1,210 $363,000
Q3 2018 Oct 23, 2018	BUY	$279.04 - $367.06 $666,068 - $876,172	2,387 Added 44.51%	7,750 $2.85 Million
Q2 2018 Aug 09, 2018	BUY	$228.17 - $292.07 $783,307 - $1 Million	3,433 Added 177.88%	5,363 $1.5 Million
Q1 2018 May 08, 2018	BUY	$209.54 - $253.91 $404,412 - $490,046	1,930 New	1,930 $456,000

899

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.